Clinical trials: RARS-T

Hematologic Malignancies, Acute Leukemia

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

• Terminated
• Age: 18 years and older
• Phase 1/2
• Injection or infusion
• Medical device
• Results posted

This is a research study involving the treatment of patients with hematological cancers with allogeneic (cells from a donor) hematopoietic stem cell transplant (HSCT). HSCT is often referred to as bone marrow transplant.

Conditions

Hematologic Malignancies, Acute Leukemia, Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes, Hodgkin's Lymphoma

Trial name

NCT01350258

Testing

Fludarabine, Thiotepa, Total Body Irradiation (TBI)

Where

United States

Volunteers

8 people

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University